Analyst Research

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mindray Medical International Ltd Revises FY 2013 Revenue Guidance To A Range In Line With Analysts' Estimates; Lowers FY 2012 Net Income Guidance; Comments On FY 2013 Revenue Guidance


Monday, 7 Jan 2013 08:01am EST 

Mindray Medical International Ltd announced that for fiscal 2012, it expects net revenue to be approximately USD1.056 billion. Based on the estimated full-year revenue, the company anticipates fiscal 2012 non-GAAP net income to be approximately USD207 million. Fiscal 2013, the Company expects revenue to grow at least 17% year-over-year, with China and other emerging markets as the primary growth contributors. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.055 billion and net income of $197 million for fiscal 2012; revenue of $1.244 billion for fiscal 2013. 

Company Quote

31.02
0.42 +1.37%
11 Jul 2014